Pillo Health, maker of conversational devices and platforms for medication adherence, has closed a $11 million Series A round led by Stanley Black & Decker’s Stanley Ventures with “significant participation” from Samsung Ventures. Existing backers BioAdvance, Hikma Ventures, Hackensack Meridien Health System’s Innovation Center Fund and Civilization Ventures also took part in the funding....
A bot by any other name. It appears that Pillo Health won’t be the only one selling its friendly home health assistant and countertop pill dispenser. Thanks to a strategic investment by Stanley Ventures, Stanley Black & Decker will be offering a slightly modified version of the device under the name of “Pria by Black+Decker Home Care Companion.” According to a representative of Stanley Black...
Pillo, the countertop device that uses conversational artificial intelligence to help patients manage their treatments, is now available to consumers for online purchase, manufacturer Pillo Health announced this morning. The device is currently being sold for $499 alongside a one-year subscription to the company’s connected service.
Designed for older patients or those with chronic diseases and...
Sophia Genetics acquires CDS software company. Genomics AI company Sophia Genetics has acquired Interactive Biosoftware, a maker of Alamut, a clinical decision support software for clinical genomic data interpretation. The terms of the deal were not disclosed.
"We are very excited about the acquisition of Interactive Biosoftware," Jurgi Camblong, CEO and cofounder at Sophia Genetics, said in a...
Pillo Health has announced a deal with AI and voice assistant company Orbita to power the former’s in-home medication adherence robot. The partnership will allow the Pillo platform, set to debut at HIMSS 2018, to better assist users with complex therapy regimens and encourage adherence.
“Combining voice-first technology with algorithms and architecture dedicated to healthcare is critical to...
